Cargando…
A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031300/ https://www.ncbi.nlm.nih.gov/pubmed/27655359 http://dx.doi.org/10.1186/s13073-016-0351-7 |
_version_ | 1782454782999396352 |
---|---|
author | O’Daniel, Julianne M. Berg, Jonathan S. |
author_facet | O’Daniel, Julianne M. Berg, Jonathan S. |
author_sort | O’Daniel, Julianne M. |
collection | PubMed |
description | For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work. |
format | Online Article Text |
id | pubmed-5031300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50313002016-09-29 A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research O’Daniel, Julianne M. Berg, Jonathan S. Genome Med Comment For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work. BioMed Central 2016-09-21 /pmc/articles/PMC5031300/ /pubmed/27655359 http://dx.doi.org/10.1186/s13073-016-0351-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Comment O’Daniel, Julianne M. Berg, Jonathan S. A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title | A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title_full | A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title_fullStr | A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title_full_unstemmed | A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title_short | A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
title_sort | missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031300/ https://www.ncbi.nlm.nih.gov/pubmed/27655359 http://dx.doi.org/10.1186/s13073-016-0351-7 |
work_keys_str_mv | AT odanieljuliannem amissinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch AT bergjonathans amissinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch AT odanieljuliannem missinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch AT bergjonathans missinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch |